Thursday, April 3, 2025
spot_img

IBA – ACQUISITION OF OWN SHARES

Immediate Release – March 31st, 2025

Louvain-la-Neuve, Belgium, March 31st, 2025 – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on March 24th, 2025.

Under this program, IBA has requested a financial intermediary to repurchase up to 650,000 IBA ordinary shares on its behalf under the terms of a mandate with validity until December 31st, 2025, effective as from March 25th, 2025, to cover the company’s obligations under long-term incentive plans for management and certain members of its personnel.

In the framework of this share buyback program, IBA repurchased 93,017 IBA shares on Euronext Brussels in the period from March 25th, 2025 up to and including March 31st, 2025, as follows:

               
  Trade date Shares purchased Average price Min price Max price Buyback amount  
  25/03/2025 6,000 11.62 € 11.44 € 11.70 € 69,727.80 €  
  26/03/2025 7,000 11.42 € 11.36 € 11.62 € 79,967.30 €  
  27/03/2025 7,000 11.30 € 11.24 € 11.40 € 79,098.60 €  
  27/03/2025 58,017 11.26 € 11.26 € 11.26 € 653,271.42 €  
  28/03/2025 7,000 11.24 € 11.18 € 11.38 € 78,686.30 €  
  31/03/2025 8,000 10.92 € 10.88 € 11.10 € 87,349.60 €  
  TOTAL 93,017 11.27 € 10.88 € 11.70 € 1,048,101.02 €  
               

These transactions include the purchase of a block of 58,017 shares at a price of 11.26 EUR/share, which was executed on March 27th, 2025 at 11:26:37 AM on the central order book of Euronext Brussels (XBRU).

The total number of shares purchased under this program therefore amounts to 93,017 since this is the first week of execution. As a result, the current situation with respect to treasury shares (held directly by IBA SA and indirectly through its subsidiary IBA Investments SRL) is the following :

           
      Shares Voting rights  
  IBA Investments SRL 51,973 103,946  
  IBA SA   406,596 473,019  
  Total – Treasury shares 458,569 576,965  
  Total – Issued shares 30,282,218 40,514,366  
  Treasury shares in % 1.51% 1.42%  
           

About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

More information can be found at: www.iba-worldwide.com

Contact person

IBA
Thomas Pevenage,
Investor Relations
[email protected]

Attachment

  • 250331-IBA-Buyback-EN

Powered by SlickText.com

Hot this week

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

Topics

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT...

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre...
spot_img

Related Articles

Popular Categories

spot_img